Drug Approvals
🇺🇸 FDA Page 21FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 241–252 of 665 articles
Big Pharma's Race for Biotech Assets Amid $170 Billion Patent Cliff
AI and Brain Organoids Combat Parkinson's and Rare Epilepsy
Merck's Cornerstone Cancer Drug at ASCO: Key Insights
States Confront Medical Chatbots Oversight Amid FDA Inaction
FDA Commissioner Resignation and Its Impact on Drug Approvals
PharmTech’s Regulatory Roundup for May 2026: Drug Approvals
Regulatory Actions in May 2026: Key Updates for Pharma
Zydus Therapeutics' Saroglitazar Receives FDA Priority Review
Pharma Leaders Advocate for Japan's R&D Investment
Oura's Entry into Cuffless Blood Pressure Monitoring
Latest Developments on Ebola, Hepatitis B, and Long Covid
STAT+: Insights on Pancreatic Cancer Ahead of ASCO 2026